Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOMEPROL vs IPRAGLIFLOZIN L-PROLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IOMEPROL vs IPRAGLIFLOZIN L-PROLINE: Safety Overview

Metric IOMEPROL IPRAGLIFLOZIN L-PROLINE
Total FAERS Reports 1,121 124
Deaths Reported 86 9
Death Rate 7.7% 7.3%
Hospitalizations 713 74
Average Patient Age 61.5 yrs 62.1 yrs
% Female Patients 49.1% 37.6%
FDA Approval Date Nov 27, 2024 N/A
Manufacturer BIPSO GmbH N/A
Route INTRA-ARTERIAL N/A
Marketing Status Discontinued N/A